1. Home
  2. DOMO vs MRVI Comparison

DOMO vs MRVI Comparison

Compare DOMO & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMO
  • MRVI
  • Stock Information
  • Founded
  • DOMO 2010
  • MRVI 2014
  • Country
  • DOMO United States
  • MRVI United States
  • Employees
  • DOMO N/A
  • MRVI N/A
  • Industry
  • DOMO Computer Software: Prepackaged Software
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • DOMO Technology
  • MRVI Health Care
  • Exchange
  • DOMO Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • DOMO 324.2M
  • MRVI 262.9M
  • IPO Year
  • DOMO 2018
  • MRVI 2020
  • Fundamental
  • Price
  • DOMO $8.23
  • MRVI $2.07
  • Analyst Decision
  • DOMO Hold
  • MRVI Hold
  • Analyst Count
  • DOMO 6
  • MRVI 9
  • Target Price
  • DOMO $10.25
  • MRVI $6.54
  • AVG Volume (30 Days)
  • DOMO 298.7K
  • MRVI 1.7M
  • Earning Date
  • DOMO 05-22-2025
  • MRVI 05-12-2025
  • Dividend Yield
  • DOMO N/A
  • MRVI N/A
  • EPS Growth
  • DOMO N/A
  • MRVI N/A
  • EPS
  • DOMO N/A
  • MRVI N/A
  • Revenue
  • DOMO $317,044,000.00
  • MRVI $259,185,000.00
  • Revenue This Year
  • DOMO $0.86
  • MRVI N/A
  • Revenue Next Year
  • DOMO $1.58
  • MRVI $14.23
  • P/E Ratio
  • DOMO N/A
  • MRVI N/A
  • Revenue Growth
  • DOMO N/A
  • MRVI N/A
  • 52 Week Low
  • DOMO $6.01
  • MRVI $1.67
  • 52 Week High
  • DOMO $10.15
  • MRVI $11.56
  • Technical
  • Relative Strength Index (RSI)
  • DOMO 58.94
  • MRVI 47.53
  • Support Level
  • DOMO $7.41
  • MRVI $1.96
  • Resistance Level
  • DOMO $7.97
  • MRVI $2.20
  • Average True Range (ATR)
  • DOMO 0.33
  • MRVI 0.12
  • MACD
  • DOMO 0.10
  • MRVI 0.05
  • Stochastic Oscillator
  • DOMO 97.58
  • MRVI 73.27

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: